3 Under‑the‑Radar Defense Contractors Quietly Building Multiyear Backlogs That Will Outlast Trump's Iran War Strategy

Textron, Huntington Ingalls, and Rocket Lab are presented as defense-linked growth names with large, multiyear backlogs rather than short-term conflict trades. Textron reported 2025 revenue of $14.8B (+8%) and a $18.8B backlog, Huntington Ingalls had a $53.1B backlog against $12.5B in annual revenue, and Rocket Lab ended 2025 with a $1.85B backlog and 2025 revenue up 38% to $602M. The article is constructive on all three stocks, but it is primarily an explanatory piece rather than new company-specific catalyst news.

Analysis

The market is increasingly treating defense as a long-duration industrial backlog story rather than a geopolitics trade. That matters because the real upside is not the headline demand spike, but the conversion of multi-year programs into higher production cadence and better margin mix; the first beneficiaries are names with enough backlog to justify capex and labor expansion, while smaller suppliers without scale risk being squeezed on lead times and working capital. In that setup, TXT looks like a quality-duration winner, but HII has the strongest “visible earnings” profile because backlog-to-revenue is so stretched that incremental throughput can surprise to the upside for several years.

The second-order trade is on suppliers and adjacent capital goods. If these programs ramp as planned, aero-structures, avionics, specialty electronics, and tooling vendors should see an order-wave that is not fully priced, but the bottleneck will be certified labor and long-lead components rather than demand. That creates a subtle bear case for pure-play primes with execution risk: investors may be underestimating how much backlog is inflated by schedule slippage and how little of it converts to cash if production inflation or program delays persist.

Contrarianly, the move may be more durable than consensus expects, but not without volatility. The market is likely overpaying for any company with “defense” in the narrative while underappreciating which businesses actually have pricing power and which are just beneficiaries of a temporary sentiment swing. Rocket Lab’s upside is highest if Neutron hits schedule, but it remains the most execution-sensitive and therefore the most vulnerable to a sharp multiple reset if first-launch timing slips by even a quarter or two.

The cleanest framework is to own the backlog compounding story and fade the most narrative-driven optimism. TXT and HII offer the best blend of visibility and duration; RKLB is a momentum name with asymmetric upside but materially higher binary risk around launch milestones and contract conversion. On a 6-12 month horizon, the trade is less about current conflict headlines and more about who can turn long-cycle demand into sustained free cash flow before the rest of the market catches up.

Key Decisions for Investors

• Long TXT on 6-12 month horizon: prefer buying on any 5-8% pullback, targeting backlog-driven multiple expansion as MV-75 visibility improves; risk is schedule slippage or commercial aviation softness.
• Long HII as a slower-burn compounding trade: add on weakness, with a 12-24 month thesis on throughput gains and backlog conversion; highest conviction among the three for earnings visibility, but watch labor/cost inflation.
• Avoid chasing RKLB after the run; if expressing upside, use call spreads into the late-2026 Neutron catalyst to cap downside from launch delay risk and valuation compression.
• Pair trade: long TXT or HII vs short a basket of higher-beta industrials with weaker backlog visibility; the defense cash-flow duration should outperform if macro growth slows.
• For tactical traders, buy TXT downside protection rather than outright selling: the key risk is not demand collapse but margin pressure if procurement costs and certification timing slip beyond the next two quarters.